{"filing":{"accession_number":"0001213900-26-086150","cik":"0001795091","ticker":"OSTX","company_name":"OS Therapies Inc","form":"8-K","filing_date":"2026-08-06","report_date":"2026-07-31","primary_document":"ea0300848-8k_ostherapies.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1795091/000121390026086150/ea0300848-8k_ostherapies.htm"},"events":[{"id":25685,"run_id":23308,"accession_number":"0001213900-26-086150","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.9,"summary":"OS Therapies Inc entered into a material definitive agreement for a secured convertible promissory note (Leonite Note) of up to $10,000,000 with an initial tranche of $1,600,000 funded on July 2, 2026, and simultaneously disclosed the creation of a Bridge Note as a direct financial obligation under Regulation D exemptions, representing a material debt financing.","company_name":"OS Therapies Inc","ticker":"OSTX","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26576,"accession_number":"0001213900-26-086150","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses entry into a material definitive agreement for a secured convertible promissory note (Leonite Note) of up to $10,000,000 with an initial tranche of $1,600,000 funded on July 2, 2026. While the section also describes a subsequent settlement agreement that would retire this debt via a $1,900,000 cash payment and 500,000 shares, the primary Item 1.01 event is the creation of the direct financial obligation—the Leonite Note—which is a debt issuance. The settlement is a subsequent transaction that modifies the original obligation's status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:22:41.597403+00:00","company_name":"","ticker":null,"filing_date":""},{"id":26577,"accession_number":"0001213900-26-086150","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 2.03 explicitly addresses creation of a direct financial obligation. The section references a \"Bridge Note\" incorporated from Item 1.01, which typically discloses material acquisition or financing transactions. A bridge note is a debt instrument used to finance operations or acquisitions, constituting a new direct financial obligation material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:22:41.597403+00:00","company_name":"","ticker":null,"filing_date":""},{"id":26578,"accession_number":"0001213900-26-086150","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"OS Therapies Inc disclosed an unregistered sale of a Bridge Note under Item 3.02, relying on Section 4(a)(2) and Regulation D exemptions. The sale to an accredited investor represents a dilutive capital raise typical of small-cap companies in need of liquidity, and bridge notes commonly convert to equity, making this a material financing event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:22:41.597403+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26576,"accession_number":"0001213900-26-086150","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses entry into a material definitive agreement for a secured convertible promissory note (Leonite Note) of up to $10,000,000 with an initial tranche of $1,600,000 funded on July 2, 2026. While the section also describes a subsequent settlement agreement that would retire this debt via a $1,900,000 cash payment and 500,000 shares, the primary Item 1.01 event is the creation of the direct financial obligation—the Leonite Note—which is a debt issuance. The settlement is a subsequent transaction that modifies the original obligation's status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:22:41.597403+00:00","company_name":"OS Therapies Inc","ticker":"OSTX","filing_date":"2026-08-06"},{"id":26577,"accession_number":"0001213900-26-086150","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 2.03 explicitly addresses creation of a direct financial obligation. The section references a \"Bridge Note\" incorporated from Item 1.01, which typically discloses material acquisition or financing transactions. A bridge note is a debt instrument used to finance operations or acquisitions, constituting a new direct financial obligation material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:22:41.597403+00:00","company_name":"OS Therapies Inc","ticker":"OSTX","filing_date":"2026-08-06"},{"id":26578,"accession_number":"0001213900-26-086150","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"OS Therapies Inc disclosed an unregistered sale of a Bridge Note under Item 3.02, relying on Section 4(a)(2) and Regulation D exemptions. The sale to an accredited investor represents a dilutive capital raise typical of small-cap companies in need of liquidity, and bridge notes commonly convert to equity, making this a material financing event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:22:41.597403+00:00","company_name":"OS Therapies Inc","ticker":"OSTX","filing_date":"2026-08-06"}]}